Binding of MDK to ALK has been shown to promote PI3K/AKT and MAPK pathway activation, enhancing cell survival and proliferation in neuroblastoma and glioma models, although the precise ligand-receptor relationship remains partially unresolved [36]. This evidence concerns the gene AKT1 and central nervous system cancer.